New tool identifies novel compound targeting causes of type 2 diabetes

A new drug screening technology has identified a new potential anti-diabetes compound -- and a powerful way to quickly test whether other molecules can have a positive effect on a critical molecular pathway believed to be central to diseases ranging from diabetes to retinitis pigmentosa, cystic fibrosis, Huntington's disease, and Alzheimer's.